tiprankstipranks
Trending News
More News >
Biotest (0N6Z) (DE:BIO)
:BIO

Biotest (BIO) Price & Analysis

Compare
4 Followers

BIO Stock Chart & Stats


Financials

BIO FAQ

What was Biotest (0N6Z)’s price range in the past 12 months?
Biotest (0N6Z) lowest stock price was €40.20 and its highest was €43.20 in the past 12 months.
    What is Biotest (0N6Z)’s market cap?
    Biotest (0N6Z)’s market cap is €1.40B.
      When is Biotest (0N6Z)’s upcoming earnings report date?
      Biotest (0N6Z)’s upcoming earnings report date is Aug 04, 2025 which is in 56 days.
        How were Biotest (0N6Z)’s earnings last quarter?
        Currently, no data Available
        Is Biotest (0N6Z) overvalued?
        According to Wall Street analysts Biotest (0N6Z)’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Biotest (0N6Z) pay dividends?
          Biotest (0N6Z) pays a Annually dividend of €0.039 which represents an annual dividend yield of 0.09%. See more information on Biotest (0N6Z) dividends here
            What is Biotest (0N6Z)’s EPS estimate?
            Biotest (0N6Z)’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Biotest (0N6Z) have?
            Biotest (0N6Z) has 19,785,727 shares outstanding.
              What happened to Biotest (0N6Z)’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Biotest (0N6Z)?
              Currently, no hedge funds are holding shares in DE:BIO

              Biotest Stock Smart Score

              4
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -4.17%
              12-Months-Change

              Fundamentals

              Return on Equity
              -4.72%
              Trailing 12-Months
              Asset Growth
              -2.09%
              Trailing 12-Months

              Company Description

              Biotest (0N6Z)

              Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophylaxis. The company's products also comprise Cytotect CP biotest for cytomegalovirus infections; Fovepta for hepatitis B prophylaxis in neonates; Hepatect for prophylaxis of hepatitis B reinfection; Intratect and IgG Next Genration for primary immune and secondary antibody deficiency syndromes and autoimmune diseases, as well as neurological indications; Varitect for the treatment of varicella zoster virus infections; and Zutectra for hepatitis B re-infection prophylaxis after liver transplantation. In addition, it provides Albiomin and Biseko to restore and maintain circulating blood volume; Cofact for the treatment of clotting factors deficiency; Fibrinogen to treat congenital fibrinogen deficiency; Trimodulin for the community-acquired pneumonia and COVID-19; and Pentaglobin to treat bacterial infections. The company was formerly known as Biotest Serum-Institut GmbH and changed its name to Biotest Aktiengesellschaft in 1986. The company was founded in 1946 and is headquartered in Dreieich, Germany. As of January 21, 2022, Biotest Aktiengesellschaft operates as a subsidiary of Grifols, S.A.
              Similar Stocks
              Company
              Price & Change
              Follow
              Eckert & Ziegler Strahlen und Medizintechnik
              Epigenomics
              Evotec
              Medios AG
              Formycon AG
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis